A study that evaluated over 4000 patients with breast cancer found that, with a median follow-up of 18 years, history of ...

Mastectomy can have major impacts on the life of a person with breast cancer, from body image issues to sexual and ...

Teclistamab plus daratumumab hyaluronidase-fihj has been approved for patients with relapsed/refractory multiple myeloma as ...

Antonio Ocejo, MD, discusses supportive care implications from new data comparing ipilimumab/nivolumab in older vs younger ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

C, MPH, stressed that nurses can take advantage of accessible and local integrative medicine resources to treat patients with ...

Dizon, MD, FACP, FASCO, shared insights on what pregnancy looks like with a breast cancer diagnosis and what those considering pregnancy should know. For young patients with breast cancer, pregnancy ...

A real-world study found rates of toxicity-related T-DXd discontinuation in HER2-low metastatic breast cancer similar to ...

Having dealt with difficult-to-diagnose breast cancer herself, Patricia Jakel, MN, RN, AOCN, is all too familiar with the ...

A significant portion of patients with locally advanced breast cancer receiving ultra-hypofractionation radiotherapy responded to treatment. Ultra-hypofractionated radiotherapy showed signs of ...

Data show that sentinel lymph node biopsy is becoming less routine for older women with breast early stage HR-positive, ...

Samantha Shenoy, NP, MSN, provides nursing guidance on teclistamab/subcutaneous daratumumab’s second-line approval in multiple myeloma. On March 5, the FDA approved ...